ProgynyPGNY
PGNY
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
179% more call options, than puts
Call options by funds: $8.57M | Put options by funds: $3.07M
1.79% more ownership
Funds ownership: 96.05% [Q3] → 97.83% (+1.79%) [Q4]
2% more capital invested
Capital invested by funds: $1.41B [Q3] → $1.44B (+$26.5M) [Q4]
7% less funds holding
Funds holding: 283 [Q3] → 262 (-21) [Q4]
22% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 97
25% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 72
67% less funds holding in top 10
Funds holding in top 10: 3 [Q3] → 1 (-2) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$23
3%
upside
Avg. target
$24
6%
upside
High target
$25
12%
upside
3 analyst ratings
1 positive
33%
2 neutral
67%
0 negative
0%
Canaccord Genuity Richard Close 46% 1-year accuracy 13 / 28 met price target | 3%upside $23 | Hold Maintained | 28 Feb 2025 |
B of A Securities Michael Cherny 68% 1-year accuracy 19 / 28 met price target | 12%upside $25 | Buy Maintained | 11 Feb 2025 |
JP Morgan Anne Samuel 51% 1-year accuracy 18 / 35 met price target | 3%upside $23 | Neutral Maintained | 28 Jan 2025 |
Financial journalist opinion
Based on 6 articles about PGNY published over the past 30 days
Neutral
GlobeNewsWire
2 weeks ago
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit navigation
Neutral
GlobeNewsWire
2 weeks ago
Progyny, Inc. to Participate in Upcoming Investor Conferences
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced it expects to participate in several upcoming investor conferences. Progyny executives will participate in a fireside chat at the Leerink Partners Global Healthcare Conference in Miami, FL on Monday, March 10, 2025, at 11:20 a.m. Eastern Time. The executives will then be participating in meetings at the Barclays 27th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 11, 2025.
Positive
Schwab Network
3 weeks ago
PGNY CEO on "Well-Positioned" Sales Year & Expanding Footprint
Pete Anevski, CEO of Progyny (PGNY), discusses his company's latest earnings and how it's poised for a "well-positioned" year. He notes general healthcare headwinds for the women's health company, though he expects Progyny to find new clients and retain current customers.
Positive
The Motley Fool
3 weeks ago
Progyny Tops EPS Forecast, Eyes Growth
Progyny (PGNY -1.68%), a pioneer in fertility benefits management, released its earnings for the fourth quarter on Feb. 27. The standout points were its impressive revenue and adjusted earnings per share (EPS) results, both of which surpassed analysts' consensus predictions.
Neutral
Seeking Alpha
3 weeks ago
Progyny, Inc. (PGNY) Q4 2024 Earnings Call Transcript
Progyny, Inc. (NASDAQ:PGNY ) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ET Company Participants James Hart - Investor Relations Pete Anevski - Chief Executive Officer Mark Livingston - Chief Financial Officer Michael Sturmer - President Conference Call Participants Anne Samuel - JPMorgan Michael Cherny - Leerink Partners John Pinney - Canaccord Genuity Scott Schoenhaus - KeyBanc Jailendra Singh - Truist Securities Allen Lutz - Bank of America Sarah James - Cantor Constantine Davides - Citizens JMP Jenny Shen - BTIG Operator Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call.
Neutral
GlobeNewsWire
4 weeks ago
Progyny, Inc. Announces Fourth Quarter 2024 Results
Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of Revenue Growth
Positive
Zacks Investment Research
1 month ago
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
GlobeNewsWire
1 month ago
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m.
Neutral
GlobeNewsWire
1 month ago
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Positive
Zacks Investment Research
1 month ago
All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Charts implemented using Lightweight Charts™